Affiliation:
1. Department of Pathophysiology and Therapeutics of Diabetic Vascular Complications, Kurume University School of Medicine, Kurume 830-0011, Japan
Abstract
Accumulating evidence has shown that the incidence of atrial fibrillation (AF) is higher in patients with diabetes, especially those with poor glycemic control or long disease duration. Nonenzymatic glycation of amino acids of proteins, lipids, and nucleic acids has progressed under normal aging process and/or diabetic condition, which could lead to the formation and accumulation of advanced glycation end products (AGEs). AGEs not only alter the tertiary structure and physiological function of macromolecules, but also evoke inflammatory and fibrotic reactions through the interaction of cell surface receptor for AGEs (RAGE), thereby being involved in aging-related disorders. In this paper, we briefly review the association of chronic hyperglycemia and type 1 diabetes with the risk of AF and then discuss the pathological role of AGE-RAGE axis in AF and its thromboembolic complications.
Publisher
Bentham Science Publishers Ltd.
Subject
Drug Discovery,Pharmacology,General Medicine
Reference163 articles.
1. IDF Diabetes Atlas-8th Edition. ext-link-type="uri" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.diabetesatlas.org/key-messages.html">http://www.diabetesatlas.org/key-messages.html (Accessed on December 17, 2018).
2. Yamagishi S.I.; Matsui T.; Therapeutic Potential of DNA-aptamers Raised Against AGE-RAGE Axis in Diabetes-related Complications. Curr Pharm Des 2018,24,2802-2809
3. Seshasai S.R.; Kaptoge S.; Thompson A.; Di Angelantonio E.; Gao P.; Sarwar N.; Whincup P.H.; Mukamal K.J.; Gillum R.F.; Holme I.; Njølstad I.; Fletcher A.; Nilsson P.; Lewington S.; Collins R.; Gudnason V.; Thompson S.G.; Sattar N.; Selvin E.; Hu F.B.; Danesh J.; Emerging risk factors collaboration, diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med 2011,364,829-841
4. Yamagishi S.; Imaizumi T.; Diabetic vascular complications: Pathophysiology, biochemical basis and potential therapeutic strategy. Curr Pharm Des 2005,11,2279-2299
5. Forbes J.M.; Cooper M.E.; Mechanisms of diabetic complications. Physiol Rev 2013,93,137-188
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献